Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolomic Consequences of Genetic Inhibition of PCSK9 Compared With Statin Treatment
Eeva Sliz, Johannes Kettunen, Michael V. Holmes, et al.
Circulation (2018) Vol. 138, Iss. 22, pp. 2499-2512
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK Biobank
Heli Julkunen, Anna Cichońska, Mika Tiainen, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 228
Systems biology in cardiovascular disease: a multiomics approach
Abhishek Joshi, Marieke Rienks, Konstantinos Theofilatos, et al.
Nature Reviews Cardiology (2020) Vol. 18, Iss. 5, pp. 313-330
Closed Access | Times Cited: 198
Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation
Tom G. Richardson, Genevieve M Leyden, Qin Wang, et al.
PLoS Biology (2022) Vol. 20, Iss. 2, pp. e3001547-e3001547
Open Access | Times Cited: 179
Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development
Michael V. Holmes, Tom G. Richardson, Brian A. Ference, et al.
Nature Reviews Cardiology (2021) Vol. 18, Iss. 6, pp. 435-453
Open Access | Times Cited: 143
NMR and Metabolomics—A Roadmap for the Future
David S. Wishart, Leo L. Cheng, Valérie Copié, et al.
Metabolites (2022) Vol. 12, Iss. 8, pp. 678-678
Open Access | Times Cited: 103
Quality control and removal of technical variation of NMR metabolic biomarker data in ~120,000 UK Biobank participants
Scott C. Ritchie, Praveen Surendran, Savita Karthikeyan, et al.
Scientific Data (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 79
Genome-wide characterization of circulating metabolic biomarkers
Minna K. Karjalainen, Savita Karthikeyan, Clare Oliver‐Williams, et al.
Nature (2024) Vol. 628, Iss. 8006, pp. 130-138
Open Access | Times Cited: 79
Genotyping and population characteristics of the China Kadoorie Biobank
Robin Walters, Iona Y. Millwood, Kuang Lin, et al.
Cell Genomics (2023) Vol. 3, Iss. 8, pp. 100361-100361
Open Access | Times Cited: 66
PCSK9 inhibition and inflammation: A narrative review
Massimiliano Ruscica, Lâle Tokgözoğlu, Alberto Corsini, et al.
Atherosclerosis (2019) Vol. 288, pp. 146-155
Open Access | Times Cited: 103
Nuclear Magnetic Resonance Spectroscopy in Clinical Metabolomics and Personalized Medicine: Current Challenges and Perspectives
Marine P. M. Letertre, Patrick Giraudeau, Pascal De Tullio
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 71
Exploring Molecular Mechanisms and Biomarkers in COPD: An Overview of Current Advancements and Perspectives
Chin-Ling Li, Shih-Feng Liu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7347-7347
Open Access | Times Cited: 8
Changes in circulating pro-protein convertase subtilisin/kexin type 9 levels – experimental and clinical approaches with lipid-lowering agents
Chiara Macchi, Maciej Banach, Alberto Corsini, et al.
European Journal of Preventive Cardiology (2019) Vol. 26, Iss. 9, pp. 930-949
Open Access | Times Cited: 73
Genetic and In Vitro Inhibition of PCSK9 and Calcific Aortic Valve Stenosis
Nicolas Perrot, Vincenza Valerio, Donato Moschetta, et al.
JACC Basic to Translational Science (2020) Vol. 5, Iss. 7, pp. 649-661
Open Access | Times Cited: 64
Apolipoprotein A-I concentrations and risk of coronary artery disease: A Mendelian randomization study
Minna K. Karjalainen, Michael V. Holmes, Qin Wang, et al.
Atherosclerosis (2020) Vol. 299, pp. 56-63
Open Access | Times Cited: 63
Diabetogenic Action of Statins: Mechanisms
Rafael Carmena, D. J. Betteridge
Current Atherosclerosis Reports (2019) Vol. 21, Iss. 6
Closed Access | Times Cited: 57
What is ‘LDL cholesterol’?
Michael V. Holmes, Mika Ala‐Korpela
Nature Reviews Cardiology (2019) Vol. 16, Iss. 4, pp. 197-198
Closed Access | Times Cited: 56
Metabolomic epidemiology offers insights into disease aetiology
Harriett Fuller, Yiwen Zhu, Jayna Nicholas, et al.
Nature Metabolism (2023) Vol. 5, Iss. 10, pp. 1656-1672
Open Access | Times Cited: 18
Increased 1H-NMR metabolomics-based health score associates with declined cognitive performance and functional independence in older adults at risk of cardiovascular disease
Michelle H. Zonneveld, Nour Al Kuhaili, Simon P. Mooijaart, et al.
GeroScience (2024)
Open Access | Times Cited: 6
The culprit is the carrier, not the loads: cholesterol, triglycerides and apolipoprotein B in atherosclerosis and coronary heart disease
Mika Ala‐Korpela
International Journal of Epidemiology (2019) Vol. 48, Iss. 5, pp. 1389-1392
Open Access | Times Cited: 47
Differences in Pregnancy Metabolic Profiles and Their Determinants between White European and South Asian Women: Findings from the Born in Bradford Cohort
Kurt Taylor, Diana L. Santos Ferreira, Jane West, et al.
Metabolites (2019) Vol. 9, Iss. 9, pp. 190-190
Open Access | Times Cited: 44
Apt interpretation of comprehensive lipoprotein data in large-scale epidemiology: disclosure of fundamental structural and metabolic relationships
Mika Ala‐Korpela, Siyu Zhao, Marjo‐Riitta Järvelin, et al.
International Journal of Epidemiology (2021) Vol. 51, Iss. 3, pp. 996-1011
Open Access | Times Cited: 34
Emerging clinical role of proprotein convertase subtilisin/kexin type 9 inhibition–Part two: Current and emerging concepts in the clinical use of PCSK9 inhibition
Alexander M. Cao Zhang, Efthymios Ziogos, Tarek Harb, et al.
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 10
Closed Access | Times Cited: 4
Elevated Remnant and LDL Cholesterol and the Risk of Peripheral Artery Disease
Benjamin Nilsson Wadström, Maria Carolina Borges, Anders Berg Wulff, et al.
Journal of the American College of Cardiology (2025) Vol. 85, Iss. 12, pp. 1353-1368
Closed Access
Association of Circulating Metabolites in Plasma or Serum and Risk of Stroke
Dina Vojinović, Marita Kalaoja, Stella Trompet, et al.
Neurology (2020) Vol. 96, Iss. 8
Open Access | Times Cited: 34
Investigating pleiotropic effects of statins on ischemic heart disease in the UK Biobank using Mendelian randomisation
C. Mary Schooling, JV Zhao, Shiu Lun Au Yeung, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top